SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 156 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,728 | +17.4% | 22,508 | +10.9% | 0.02% | +12.5% |
| Q2 2023 | $2,323 | -30.8% | 20,288 | -16.6% | 0.02% | -30.4% |
| Q1 2023 | $3,355 | +9.9% | 24,338 | +3.3% | 0.02% | +4.5% |
| Q4 2022 | $3,052 | -99.9% | 23,554 | -13.5% | 0.02% | 0.0% |
| Q3 2022 | $3,009,000 | +205.2% | 27,224 | +106.9% | 0.02% | +214.3% |
| Q2 2022 | $986,000 | -26.6% | 13,158 | -23.5% | 0.01% | 0.0% |
| Q1 2022 | $1,343,000 | +3.8% | 17,195 | +19.6% | 0.01% | +16.7% |
| Q4 2021 | $1,294,000 | +18.9% | 14,375 | +22.1% | 0.01% | 0.0% |
| Q3 2021 | $1,088,000 | +44.7% | 11,770 | +21.7% | 0.01% | +50.0% |
| Q2 2021 | $752,000 | -47.9% | 9,672 | -50.1% | 0.00% | -50.0% |
| Q1 2021 | $1,444,000 | -53.3% | 19,371 | +6.9% | 0.01% | -57.9% |
| Q4 2020 | $3,091,000 | +74.5% | 18,128 | +43.8% | 0.02% | +72.7% |
| Q3 2020 | $1,771,000 | -63.0% | 12,608 | -57.8% | 0.01% | -71.8% |
| Q2 2020 | $4,786,000 | +465.1% | 29,849 | +244.9% | 0.04% | +333.3% |
| Q1 2020 | $847,000 | -25.0% | 8,655 | -1.2% | 0.01% | 0.0% |
| Q4 2019 | $1,130,000 | +71.7% | 8,757 | +0.2% | 0.01% | +50.0% |
| Q3 2019 | $658,000 | -44.3% | 8,742 | +19.4% | 0.01% | -25.0% |
| Q3 2018 | $1,182,000 | -28.2% | 7,320 | -41.2% | 0.01% | -20.0% |
| Q2 2018 | $1,646,000 | +63.8% | 12,450 | -8.2% | 0.01% | +42.9% |
| Q1 2018 | $1,005,000 | -12.0% | 13,566 | -33.9% | 0.01% | -12.5% |
| Q4 2017 | $1,142,000 | +414.4% | 20,528 | +319.2% | 0.01% | +700.0% |
| Q3 2017 | $222,000 | -23.2% | 4,897 | +3.9% | 0.00% | -50.0% |
| Q3 2016 | $289,000 | +151.3% | 4,712 | -21.9% | 0.00% | +100.0% |
| Q2 2016 | $115,000 | +10.6% | 6,034 | +13.6% | 0.00% | 0.0% |
| Q1 2016 | $104,000 | -31.1% | 5,310 | +35.5% | 0.00% | 0.0% |
| Q4 2015 | $151,000 | -2.6% | 3,918 | -18.9% | 0.00% | 0.0% |
| Q3 2015 | $155,000 | +229.8% | 4,833 | +216.1% | 0.00% | – |
| Q2 2015 | $47,000 | +193.8% | 1,529 | +28.6% | 0.00% | – |
| Q1 2015 | $16,000 | -5.9% | 1,189 | +0.9% | 0.00% | – |
| Q4 2014 | $17,000 | -41.4% | 1,178 | -14.9% | 0.00% | – |
| Q3 2014 | $29,000 | -27.5% | 1,385 | +3.4% | 0.00% | – |
| Q2 2014 | $40,000 | +25.0% | 1,340 | 0.0% | 0.00% | – |
| Q1 2014 | $32,000 | +33.3% | 1,340 | +12.7% | 0.00% | – |
| Q4 2013 | $24,000 | -86.9% | 1,189 | -69.3% | 0.00% | -100.0% |
| Q3 2013 | $183,000 | +134.6% | 3,873 | +88.0% | 0.00% | +100.0% |
| Q2 2013 | $78,000 | – | 2,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |